What does this research mean for the field?

Oral MK-954 (DuP 753) is effective and safe for the management of essential hypertension. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 1, 1991Journal of Hypertension

Efficacy and safety of oral MK-954 (DuP 753), an angiotensin receptor antagonist, in essential hypertension

View Full Paper

Ask AI

Bookmark

Key result

Oral MK-954 undergoes evaluation for efficacy and safety in essential hypertension.

Design

Other

Authors

ENE. NelsonMerck & Co., Inc., Rahway, NJ, USA (United States)DMD. MerrillMerck & Co., Inc., Rahway, NJ, USA (United States)CSC. SweetUnited States Naval Academy

Discussion

Member takes

Implication

Initial ARB evaluation in hypertension supports further development; leaves open definitive efficacy and safety in randomized trials.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Nelson et al. (1991) studied this question. Oral MK-954 (DuP 753), an angiotensin receptor antagonist, was evaluated for its efficacy and safety in patients with essential hypertension.

synapsesocial.com/papers/6aa895946d30d9da665cc2cd https://doi.org/10.1097/00004872-199112006-00300

View Full Paper

Ask AI

Bookmark

Efficacy and safety of oral MK-954 (DuP 753), an angiotensin receptor antagonist, in essential hypertension

Discussion

Member takes

Implication

Key Points

Cite This Study

Efficacy and safety of oral MK-954 (DuP 753), an angiotensin receptor antagonist, in essential hypertension

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider